[Fluvastatin induces apoptosis on human tongue carcinoma cell line HSC-3]
Kimiko Fujiwara1, Masanobu Tsubaki, Yuzuru Yamazoe
1Department of Pharmacy, Kinki University Hospital, Osakasayama City, Japan.
Abstract:
Statins, which are inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, suppress cell proliferation and induce apoptosis in various cancer cell lines. However, the effects of statins in head and neck carcinoma have not been reported. In this study, we investigated the mechanism by which fluvastatin induces apoptosis in HSC-3 cells. An increase in caspase-3 activity was observed. The apoptosis induced by fluvastatin was inhibited by the addition of geranylgeranyl pyrophosphate (GGPP) to the cell culture. When we examined the survival signals at the time of apoptotic induction, we also found that fluvastatin had caused a remarkable decrease in the phosphorylation of extracellular signal-regulated kinase (ERK) 1/2. Moreover, we also found that U0126, a MEK1/2 inhibitor, induces apoptosis in HSC-3 cells. These results suggested that fluvastatin induces apoptosis by inhibiting GGPP biosynthesis and consequently decreasing the level of phosphorylated ERK1/2. The results of this study also indicate that fluvastatin may be used as an anticancer agent for tongue carcinoma.
Insights
Fluvastatin, a statin drug, induces cancer cell death (apoptosis) in tongue carcinoma by blocking essential cell survival signals. This mechanism suggests fluvastatin
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Statins inhibit 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase and suppress cancer cell proliferation.
- The anti-cancer effects of statins on head and neck carcinoma remain largely uninvestigated.
Purpose of the Study:
- To elucidate the mechanism by which fluvastatin induces apoptosis in human tongue squamous cell carcinoma (HSC-3) cells.
- To explore the potential of fluvastatin as an anti-cancer therapeutic for tongue carcinoma.
Main Methods:
- Investigated fluvastatin's effect on caspase-3 activity and apoptosis induction in HSC-3 cells.
- Assessed the impact of geranylgeranyl pyrophosphate (GGPP) supplementation on fluvastatin-induced apoptosis.
- Analyzed the phosphorylation status of extracellular signal-regulated kinase (ERK) 1/2 following fluvastatin treatment.
- Utilized U0126, a MEK1/2 inhibitor, to further investigate the role of the ERK pathway.
Main Results:
- Fluvastatin significantly increased caspase-3 activity, indicating apoptosis induction.
- The addition of GGPP reversed the apoptotic effects of fluvastatin.
- Fluvastatin treatment led to a marked decrease in phosphorylated ERK1/2 levels.
- U0126, a MEK1/2 inhibitor, also induced apoptosis in HSC-3 cells.
Conclusions:
- Fluvastatin induces apoptosis in tongue carcinoma cells by inhibiting GGPP biosynthesis, which subsequently reduces phosphorylated ERK1/2 levels.
- These findings suggest that fluvastatin holds promise as a potential anti-cancer agent for tongue carcinoma.
